Lifestyle Determinants and Metabolic Compensation in Pregnancies Complicated by Type 1 Diabetes: A Synthesis of the ENDIA Study and Recent Evidence

Highlights

• Evidence from the ENDIA study indicates that a majority of pregnant women, regardless of type 1 diabetes (T1D) status, fail to meet national dietary guidelines, with excessive intake of saturated fats and sodium.
• Physical activity significantly declines in the third trimester across all groups, with women with T1D performing less vigorous intensity activity compared to those without the condition.
• Prospective cohort data from the DIPP study suggests that higher intakes of vitamins C and E are associated with a reduced risk of islet autoimmunity in genetically at-risk children, highlighting the importance of maternal and early childhood nutrition.
• Novel molecular pathways, such as the ENPP2-mediated beta-cell compensation and the alpha7nAChR-mediated mitochondrial protection, provide mechanistic insights into how the body adapts to metabolic stress during pregnancy.

Background

Pregnancy represents a unique physiological state of increased metabolic demand and transient insulin resistance. For women with type 1 diabetes (T1D), managing this state is critical to prevent adverse maternal and neonatal outcomes. However, the environmental and lifestyle determinants that influence these outcomes—specifically diet and physical activity—remain under-researched in large-scale prospective cohorts. The Environmental Determinants of Islet Autoimmunity (ENDIA) study provides a robust framework for comparing lifestyle behaviors in women with T1D against those without the condition. Furthermore, understanding how these lifestyle factors interact with genetic predispositions and molecular compensatory mechanisms is essential for developing evidence-based clinical guidelines. This review synthesizes recent clinical findings from the ENDIA and DIPP studies with emerging translational research on metabolic health during pregnancy.

Key Content

The ENDIA Study: Clinical Findings on Diet and Exercise

The ENDIA study prospectively followed 1,124 pregnancies to compare lifestyle behaviors. The results revealed a startling gap between clinical recommendations and actual behavior.

Dietary Patterns: Most participants exceeded the recommended intake for total fat, saturated fat, sodium, and discretionary foods. Conversely, they fell below the guidelines for carbohydrates, fruits, vegetables, dairy, and lean meats. Interestingly, the dietary differences between women with and without T1D were modest, suggesting that the presence of T1D does not necessarily lead to superior adherence to general health guidelines, despite more frequent contact with healthcare providers.

Physical Activity: Both groups showed a significant reduction in total, moderate, and vigorous physical activity during the third trimester. However, women with T1D performed significantly less vigorous activity than their counterparts. This may reflect a clinical caution regarding exercise-induced hypoglycemia or other T1D-specific complications, pointing to a need for more tailored exercise prescriptions in this population.

Nutritional Adequacy and Islet Autoimmunity

While the ENDIA study focuses on maternal behavior, the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) cohort provides complementary insights into how specific nutrients affect the next generation.

Data from 5,674 children in the DIPP study (PMID: 41413297) demonstrated that higher dietary intake of vitamin C and vitamin E was significantly associated with a decreased risk of islet autoimmunity. This suggests that the “dietary gaps” identified in the ENDIA study—specifically low vegetable and fruit intake—could have long-term implications for the child’s risk of developing T1D. Furthermore, the EAT-Lancet planetary health diet study (PMID: 41692025) highlights that while high adherence to plant-based diets can improve micronutrient status (folate, vitamins A, E, C), it may increase the risk of anemia in women, necessitating careful monitoring of iron and hemoglobin levels during the childbearing years.

Mechanistic Insights into Metabolic Compensation

Translational research is beginning to uncover why certain individuals compensate better for the metabolic stress of pregnancy and obesity than others.

Islet Beta-Cell Proliferation: Research into the phosphodiesterase ENPP2 (PMID: 41454014) identifies it as a key molecule co-upregulated during both obesity and pregnancy. ENPP2 appears essential for beta-cell compensation; its absence leads to insufficient insulin secretion under metabolic stress. The study found that estrogen and progesterone synergistically upregulate ENPP2, facilitating the proliferation required to meet the insulin demands of pregnancy. This provides a biological rationale for why hormonal fluctuations are so critical to glucose homeostasis.

Mitochondrial Protection in Gestational Stress: In pregnancies complicated by gestational diabetes (GDM) or T1D, mitochondrial dysfunction in the placenta is a major concern. Recent studies on the alpha7 nicotinic acetylcholine receptor (α7nAChR) (PMID: 41396300) show that its activation can rescue mitochondrial function by regulating calcium homeostasis. This receptor competes with pro-oxidant proteins to prevent mitochondrial pore overactivation, suggesting a potential pharmacological target for mitigating placental pathology.

Novel Dietary Interventions and Future Therapeutic Directions

Beyond traditional guidelines, new evidence suggests that meal timing and specific protein sources may optimize glycemic control. A randomized crossover trial (PMID: 41578008) indicated that a dairy-enriched diet with a high-protein breakfast and early daytime-restricted carbohydrate intake improved circadian clock gene expression and glycemic indices in patients with diabetes. Specifically, the dairy-enriched intervention increased “Time in Range” (TIR) by 9% and reduced fasting glucose levels. These findings offer a more nuanced approach to dietary counseling than simple caloric restriction.

Expert Commentary

The findings from the ENDIA study underscore a significant clinical challenge: the “adherence gap.” Even in high-risk pregnancies, such as those involving T1D, dietary habits often mirror the poor nutritional patterns of the general population. This suggests that current education strategies may be insufficient.

Clinicians should move beyond generic advice and focus on high-impact changes, such as increasing vitamin C and E intake (due to their role in autoimmunity protection) and encouraging moderate, consistent physical activity into the third trimester. The reduced vigorous activity in T1D patients likely reflects a fear of hypoglycemia; therefore, the integration of Continuous Glucose Monitoring (CGM) data with exercise plans is essential for patient confidence.

Furthermore, the genetic and molecular findings—such as the CUBN gene’s role in metformin-induced B12 deficiency (PMID: 41537778) and the ENPP2 pathway—highlight the move toward “precision nutrition.” We are entering an era where dietary recommendations may be tailored not just to a disease state, but to an individual’s genetic ability to absorb nutrients and their biological capacity for beta-cell compensation.

Conclusion

Managing lifestyle in pregnancies complicated by type 1 diabetes remains a complex task. The ENDIA study demonstrates that most women do not meet nutritional or exercise guidelines, with specific deficits in carbohydrate quality and vigorous activity. However, emerging evidence on the protective effects of specific micronutrients against islet autoimmunity and the discovery of molecular pathways like ENPP2 offer hope for more targeted interventions. Future research must bridge the gap between these mechanistic insights and clinical practice, ensuring that maternal lifestyle is optimized not just for glycemic control, but for the lifelong health of the child.

References

• Thomson RL, et al. A Comparison of Diet and Exercise During Pregnancy in Women With and Without Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. Diabetes Care. 2026;49(3):471-477. PMID: 41543932.
• Mattsson HW, et al. Nutritional adequacy of the EAT-Lancet diet: a Swedish population-based cohort study. Lancet Planet Health. 2027;101416. PMID: 41692025.
• Sarkkola E, et al. Dietary intake of vitamins A, B, C, D and E and risk of islet autoimmunity and type 1 diabetes in genetically at-risk children: a prospective study from the DIPP birth cohort. Diabetologia. 2026;69(4):917-929. PMID: 41413297.
• Li J, et al. Phosphodiesterase ENPP2, which is co-upregulated in obese and pregnant mice, is essential for islet beta cell compensation during obesity. Diabetologia. 2026;69(4):1000-1020. PMID: 41454014.
• Zhang Y, et al. α7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding. Diabetologia. 2026;69(4):1081-1099. PMID: 41396300.
• Froy O, et al. Glycaemic, appetite and circadian benefits of a dairy-enriched diet with high-protein breakfast and early daytime-restricted carbohydrate intake in type 2 diabetes: a randomised crossover trial. Diabetologia. 2026;69(4):1021-1034. PMID: 41578008.